Researchers investigated the inhibitory effect of microRNA-561-3p on ZEB1, HIF1A, and MYC expression as oncogenes that have the most impact on programmed death ligand 1 (PD-L1) overexpression and cellular processes such as proliferation, apoptosis, and cell cycle in breast cancer cell lines
[Scientific Reports]